Valuation: Medios AG

Market Cap 25Cr 28Cr 23Cr 21Cr 39Cr 2.64TCr 39Cr 275.69Cr 109.15Cr 1.38TCr 104.22Cr 102.01Cr 4.35TCr P/E 2026 *
12x
P/E 2027 * 8.43x
Enterprise Value 34Cr 39Cr 32Cr 29Cr 54Cr 3.66TCr 55Cr 382.41Cr 151.4Cr 1.92TCr 144.57Cr 141.49Cr 6.04TCr EV / Sales 2026 *
0.16x
EV / Sales 2027 * 0.14x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day-0.78%
1 week-2.50%
Current month-9.32%
1 month+1.20%
3 months-19.30%
6 months-23.68%
Current year-30.11%
1 week 10.1
Extreme 10.1
10.52
1 month 10.1
Extreme 10.1
11.52
Current year 9.98
Extreme 9.98
17.44
1 year 9.98
Extreme 9.98
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 01/02/2026
Director of Finance/CFO 54 15/04/2026
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 07/11/2014
Director/Board Member 65 14/09/2016
Director/Board Member 57 10/06/2021
Date Insider Type Main position Quantity % Market Cap. Importance
12/08/26 Buy

Chief Financial Officer

3,500 0.0137%
04/02/26 Sell

Chief Executive Officer

13,638 0.0535%
22/01/26 Buy

Executive/Senior Manager

4,000 0.0157%
Change 5-day change 1-year change 3-year change Capi.($)
-0.78%-2.50%-20.06%-28.63% 28Cr
-2.54%+1.31%+55.10%+120.84% 1,13500Cr
-1.42%+3.23%+37.07%+74.26% 64TCr
+0.16%+0.08%+25.14%+97.36% 50TCr
-0.31%+3.09%+43.92%+64.55% 38TCr
-1.34%-0.47%+66.63%+40.56% 36TCr
-0.68%+2.65%+22.46%+51.48% 29TCr
-1.20%+3.04%+2.62%+26.97% 27TCr
-1.79%+1.57%+49.97%+60.87% 24TCr
-0.73%-0.10%+29.24%+101.19% 19TCr
Average -0.68%+1.70%+31.21%+60.94% 40.05TCr
Weighted average by Cap. -0.26%+2.66%+40.99%+82.12%

Financials

2026 *2027 *
Net sales 216.75Cr 242.72Cr 200.24Cr 181.46Cr 339.49Cr 23TCr 345.1Cr 2.41TCr 953.98Cr 12TCr 910.92Cr 891.55Cr 38TCr 224.67Cr 251.59Cr 207.55Cr 188.09Cr 351.88Cr 24TCr 357.7Cr 2.5TCr 988.81Cr 13TCr 944.18Cr 924.1Cr 39TCr
Net income 2.08Cr 2.33Cr 1.92Cr 1.74Cr 3.25Cr 220.73Cr 3.31Cr 23Cr 9.14Cr 115.65Cr 8.73Cr 8.54Cr 364.61Cr 2.95Cr 3.3Cr 2.73Cr 2.47Cr 4.62Cr 313.66Cr 4.7Cr 33Cr 13Cr 164.34Cr 12Cr 12Cr 518.12Cr
Net Debt 9.6Cr 11Cr 8.87Cr 8.04Cr 15Cr 1.02TCr 15Cr 106.72Cr 42Cr 534.67Cr 40Cr 39Cr 1.69TCr 5.66Cr 6.34Cr 5.23Cr 4.74Cr 8.87Cr 601.86Cr 9.01Cr 63Cr 25Cr 315.34Cr 24Cr 23Cr 994.17Cr
Projected Income Statement - Annual - Medios AG
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
989
Date Price Change Volume
23/26/23 €10.12 -0.78% 8,920
22/26/22 €10.20 -1.92% 24,384
21/26/21 €10.40 -0.38% 3,554
20/26/20 €10.44 +2.35% 18,322
19/26/19 €10.20 -1.73% 14,977
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Medios AG
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
10.12EUR
Average target price
20.25EUR
Spread / Average Target
+100.10%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Medios AG
  1. Stock Market
  2. Stocks
  3. ILM1 Stock